(Q41942143)

14 October 2017

Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance (English)

1 reference

14 October 2017

0 references

Nyunt MM

1

1 reference

PubMed ID

17898709

14 October 2017

Plowe CV

series ordinal

2

1 reference

PubMed ID

17898709

14 October 2017

language of work or name

English

0 references

publication date

26 September 2007

1 reference

Clinical Pharmacology & Therapeutics

14 October 2017

1 reference

14 October 2017

82

1 reference

14 October 2017

5

1 reference

14 October 2017

601-605

1 reference

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review

14 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

1 reference

7 January 2021

Combination treatment for falciparum prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

The evolution of drug-resistant malaria: the role of drug elimination half-life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Tolerance is the key to understanding antimalarial drug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Coartem (artemether-lumefantrine) in Africa: the beginning of the end?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Return of chloroquine antimalarial efficacy in Malawi.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Malaria-infected mice are cured by a single dose of novel artemisinin derivatives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Chemotherapy of malaria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Antimalarial drug discovery: old and new approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Structure-based approaches to the development of novel anti-malarials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Zolpidem extended-release.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Physical and chemical evaluation of liposomes, containing artesunate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100361

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100361

1 reference

14 October 2017

1 reference

PubMed ID

17898709